Search

Elekta AB

Slēgts

48.84 -0.41

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

48.66

Max

49.36

Galvenie mērījumi

By Trading Economics

Ienākumi

443M

136M

Pārdošana

-1.5B

3.6B

P/E

Sektora vidējais

66.667

36.442

EPS

0.31

Dividenžu ienesīgums

5.02

Peļņas marža

3.73

Darbinieki

4,485

EBITDA

385M

509M

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

5.02%

3.00%

Nākamie ieņēmumi

2025. g. 26. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-391M

18B

Iepriekšējā atvēršanas cena

49.25

Iepriekšējā slēgšanas cena

48.84

Elekta AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 19. okt. 20:00 UTC

Iegādes, apvienošanās, pārņemšana

Infratil Agrees to NZ$437.7 Million Deal to Raise Contact Energy Stake

2025. g. 19. okt. 23:44 UTC

Tirgus saruna

Gold Edges Lower Amid Signs of U.S.-China Trade Tensions Easing -- Market Talk

2025. g. 19. okt. 23:37 UTC

Tirgus saruna

New Zealand's Core CPI Keeps Rate Cut Hopes Alive -- Market Talk

2025. g. 19. okt. 23:36 UTC

Tirgus saruna

Nikkei May Rise, Tracking Wall Street Gains -- Market Talk

2025. g. 19. okt. 23:36 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 19. okt. 23:09 UTC

Tirgus saruna

Could Rio Tinto, BHP Ally to Defend Iron-Ore Pricing Power? -- Market Talk

2025. g. 19. okt. 22:41 UTC

Iegādes, apvienošanās, pārņemšana

Luxury Fashion House Kering Confirms Beauty Deal With L'Oréal -- Barrons.com

2025. g. 19. okt. 22:30 UTC

Peļņas

Stock Futures Rise Ahead of Major Week of Earnings -- Barrons.com

2025. g. 19. okt. 22:18 UTC

Tirgus saruna

Gold at $5,000 on Cards as Investors Get Comfortable -- Market Talk

2025. g. 19. okt. 21:50 UTC

Tirgus saruna

Infratil's Contact Stake Buy May Require Bigger Asset Sales -- Market Talk

2025. g. 19. okt. 21:15 UTC

Tirgus saruna

Investors Need to Change Narrative Toward Scales -- Market Talk

2025. g. 19. okt. 19:34 UTC

Iegādes, apvienošanās, pārņemšana

Infratil's Contact Shareholding to Rise to 14.3% When Deal Completes

2025. g. 19. okt. 19:34 UTC

Iegādes, apvienošanās, pārņemšana

Infratil to Issue New Shares Worth NZ$218.8 Million to TECT at NZ$12.43 Each

2025. g. 19. okt. 19:33 UTC

Iegādes, apvienošanās, pārņemšana

Infratil Part-Funding Purchase of Contact Energy Stake With NZ$218.8 Million of Existing Debt

2025. g. 19. okt. 19:32 UTC

Iegādes, apvienošanās, pārņemšana

Infratil Acquiring Additional Contact Energy Stake for NZ$8.95/Share

2025. g. 19. okt. 19:32 UTC

Iegādes, apvienošanās, pārņemšana

Infratil Acquiring Contact Energy Stake for NZ$437.7 Million

2025. g. 19. okt. 19:31 UTC

Iegādes, apvienošanās, pārņemšana

Infratil Acquiring TECT Holdings's Shareholding in Contact Energy

2025. g. 19. okt. 19:31 UTC

Iegādes, apvienošanās, pārņemšana

Infratil to Acquire Additional 4.92% Stake in Contact Energy

2025. g. 19. okt. 16:29 UTC

Peļņas

Elon Musk Pay Drama Heats Up Ahead of Tesla Earnings -- Barrons.com

2025. g. 19. okt. 11:14 UTC

Peļņas

Zijin Mining 3Q Oper Income CNY86.49B; up 8.1% on Year>2899.HK

2025. g. 19. okt. 11:14 UTC

Peļņas

Zijin Mining: Higher Sales of Gold, Copper Supported Results >2899.HK

2025. g. 19. okt. 11:14 UTC

Peļņas

Zijin Mining 3Q Net CNY14.57B; up 57.1% on Year>2899.HK

2025. g. 18. okt. 13:30 UTC

Iegādes, apvienošanās, pārņemšana

Deal Expected to Value Unit at Roughly $4B, Sources Say -- WSJ

2025. g. 18. okt. 13:30 UTC

Iegādes, apvienošanās, pārņemšana

Deal Could Be Announced as Soon as Next Week, Sources Say -- WSJ

2025. g. 18. okt. 13:30 UTC

Iegādes, apvienošanās, pārņemšana

Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L'Oréal -- WSJ

2025. g. 18. okt. 13:30 UTC

Iegādes, apvienošanās, pārņemšana

Gucci Parent Kering in Talks to Sell Beauty Business to L'Oréal, Sources Say -- WSJ

2025. g. 18. okt. 08:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 17. okt. 23:25 UTC

Iegādes, apvienošanās, pārņemšana

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

2025. g. 17. okt. 22:15 UTC

Tirgus saruna

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

2025. g. 17. okt. 21:15 UTC

Tirgus saruna

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

Elekta AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Elekta AB

Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit; Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Leksell GammaPlan, a treatment planning and management software. In addition, the company offers Elekta ONE, a software suite of multiple Elekta solutions. Further, it provides brachytherapy products, including Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Elekta Xoft Axxent, and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Additionally, the company offers neurosurgery products, such as Leksell Vantage Stereotactic System for intracranial neurosurgery. Furthermore, it provides Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
help-icon Live chat